Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Dinubile

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2008
Double-blind active-control trials: beware the comparator you keepMark J Dinubile
Current Infectious Disease Reports|August 9, 2008
Nodular lymphangitis: a distinctive clinical entity with finite etiologiesMark J DiNubile
Open Forum Infectious Diseases|July 7, 2016
Noninferior Antibiotics: When Is "Not Bad" "Good Enough"?Mark J DiNubile
Arthritis Research & Therapy|December 25, 2008
Plasma gelsolin as a biomarker of inflammationMark J DiNubile
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Complicated infections of skin and skin structures: when the infection is more than skin deepMark J DiNubile, Benjamin A Lipsky
Clinical Infection in Practice|August 16, 2021
Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumoniaJulie V Catteeuw, Mark J DiNubile
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for cliniciansDavid E Nix, Anup K Majumdar, Mark J DiNubile
The Journal of Infection|May 24, 2005
Invasive candidiasis in cancer patients: observations from a randomized clinical trialMark J DiNubile, Darcy Hille, Carole A Sable, et al.
AIDS Patient Care and Stds|February 16, 2006
Erectile dysfunction in an urban HIV-positive populationAlexander R Ende, Vincent Lo Re, Mark J DiNubile, et al.
Open Forum Infectious Diseases|August 5, 2022
Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 PneumoniaMark J DiNubile, Sandra Parra, Antoni Castro Salomó, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2008
Double-blind active-control trials: beware the comparator you keepMark J Dinubile
Current Infectious Disease Reports|August 9, 2008
Nodular lymphangitis: a distinctive clinical entity with finite etiologiesMark J DiNubile
Open Forum Infectious Diseases|July 7, 2016
Noninferior Antibiotics: When Is "Not Bad" "Good Enough"?Mark J DiNubile
Arthritis Research & Therapy|December 25, 2008
Plasma gelsolin as a biomarker of inflammationMark J DiNubile
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Complicated infections of skin and skin structures: when the infection is more than skin deepMark J DiNubile, Benjamin A Lipsky
Clinical Infection in Practice|August 16, 2021
Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumoniaJulie V Catteeuw, Mark J DiNubile
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for cliniciansDavid E Nix, Anup K Majumdar, Mark J DiNubile
The Journal of Infection|May 24, 2005
Invasive candidiasis in cancer patients: observations from a randomized clinical trialMark J DiNubile, Darcy Hille, Carole A Sable, et al.
AIDS Patient Care and Stds|February 16, 2006
Erectile dysfunction in an urban HIV-positive populationAlexander R Ende, Vincent Lo Re, Mark J DiNubile, et al.
Open Forum Infectious Diseases|August 5, 2022
Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 PneumoniaMark J DiNubile, Sandra Parra, Antoni Castro Salomó, et al.
Pageof 10